C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis
Neuroscience Letters, ISSN: 0304-3940, Vol: 713, Page: 134523
2019
- 19Citations
- 79Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations19
- Citation Indexes19
- CrossRef19
- 18
- Captures79
- Readers79
- 79
- Mentions1
- News Mentions1
- News1
Most Recent News
C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis.
Neurosci Lett. 2019 Sep 27;:134523. Authors: Lai JD, Ichida JK PubMed: 31568865 Submit Comment
Review Description
Amyotrophic lateral sclerosis (ALS) is a rapidly progressing disease that affects upper and lower motor neurons eventually leading to paralysis and death by respiratory dysfunction. The most common genetic variant among ALS patients is a hexanucleotide repeat expansion within the first intron of the gene C9ORF72. This expansion elicits a complex cascade of events as a result of both gain- and loss-of-function mechanisms that contribute to neurodegeneration. Increasing evidence suggests that this repeat expansion in C9ORF72 also influences the immune homeostasis. In this review, we consolidate the current understanding of C9ORF72 -mediated pathogenesis in both the central nervous system and peripheral immune system and propose mechanisms by which the immune system contributes to ALS.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0304394019306263; http://dx.doi.org/10.1016/j.neulet.2019.134523; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85072949971&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/31568865; https://linkinghub.elsevier.com/retrieve/pii/S0304394019306263; https://dx.doi.org/10.1016/j.neulet.2019.134523
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know